There May Be Reason For Hope In Amdocs' (NASDAQ:DOX) Disappointing Earnings
There May Be Reason For Hope In Amdocs' (NASDAQ:DOX) Disappointing Earnings
The market for Amdocs Limited's (NASDAQ:DOX) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.
Amdocs Limited(納斯達克股票代碼:DOX)在最近公佈疲軟的收益後,其股票市場沒有太大波動。我們的分析表明,儘管利潤疲軟,但業務基礎卻很牢固。
The Impact Of Unusual Items On Profit
不尋常物品對利潤的影響
Importantly, our data indicates that Amdocs' profit was reduced by US$131m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Amdocs doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
重要的是,我們的數據表明,由於不尋常的項目,Amdocs的利潤比去年減少了1.31億美元。看到不尋常的項目使公司利潤損失從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。鑑於這些單列項目被認爲不尋常,這並不奇怪。如果Amdocs不認爲這些不尋常的支出重演,那麼在其他條件相同的情況下,我們預計其利潤將在來年增加。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以點擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。
Our Take On Amdocs' Profit Performance
我們對Amdocs利潤表現的看法
Unusual items (expenses) detracted from Amdocs' earnings over the last year, but we might see an improvement next year. Because of this, we think Amdocs' earnings potential is at least as good as it seems, and maybe even better! Unfortunately, though, its earnings per share actually fell back over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. While it's really important to consider how well a company's statutory earnings represent its true earnings power, it's also worth taking a look at what analysts are forecasting for the future. At Simply Wall St, we have analyst estimates which you can view by clicking here.
去年,不尋常的項目(支出)減少了Amdocs的收益,但明年我們可能會看到改善。因此,我們認爲Amdocs的盈利潛力至少和看起來一樣好,甚至可能更好!但不幸的是,其每股收益實際上在去年有所回落。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。儘管考慮公司的法定收益如何代表其真正的盈利能力非常重要,但也值得一看分析師對未來的預測。在Simply Wall ST,我們有分析師的估計,您可以點擊此處查看。
This note has only looked at a single factor that sheds light on the nature of Amdocs' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
這份報告只研究了揭示Amdocs利潤性質的單一因素。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份擁有高股本回報率的公司的免費集合,或者這份內部所有權高的股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件給編輯組(網址爲)simplywallst.com。
Simply Wall ST 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。
譯文內容由第三人軟體翻譯。